Lipid parameters for measuring risk of cardiovascular disease

@article{Arsenault2011LipidPF,
  title={Lipid parameters for measuring risk of cardiovascular disease},
  author={Benoit J. Arsenault and S. Matthijs Boekholdt and John J. P. Kastelein},
  journal={Nature Reviews Cardiology},
  year={2011},
  volume={8},
  pages={197-206}
}
Besides measuring blood pressure and glucose levels, assessing the lipid spectrum is the method most commonly used to identify individuals at high risk of cardiovascular disease (CVD), as well as those who are likely to benefit most from lipid-lowering therapy. Although lowering LDL-cholesterol levels is the primary target of therapy in most clinical guidelines, accumulating evidence indicates that other lipoprotein–lipid measurements could provide a predictive value over and above that of LDL… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 52 extracted citations

Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice.

The Journal of biological chemistry • 2016
View 7 Excerpts
Highly Influenced

Apolipoprotein C-I Polymorphism and Its Association with Serum Lipid Levels and Longevity in the Bama Population

International journal of environmental research and public health • 2017
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 140 references

VISTA - 16 trial : evaluation of safety and efficacy of short - term A - 002 treatment in subjects with acute coronary syndrome [ online ]

P. Libby
2011

C - reactive protein and cardiovascular risk : more fuel to the fire

A. Cartier
Lancet • 2010

C - reactive protein concentration and risk of coronary heart disease , stroke , and mortality : an individual participant meta - analysis

P. Elliott
Lancet • 2010

Similar Papers

Loading similar papers…